Polymyxin B
Product Images NDC 45932-0030

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 45932-0030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Aps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Polymyxin (Polymyxin Carton)

This is a drug label for Polymyxin B Sulfate used for intramuscular, intravenous, and/or intrathecal administration in hospitals. The drug may be neuro- and nephrotoxic and should be administered under constant supervision by a physician. Dosages should not exceed 25,000 units per kg per day. The drug comes in a lyophilized form and each vial contains Polymyxin B Sulfate equivalent to 500,000 polymyxin B units. The label also includes storage instructions and a warning message for healthcare professionals to read the accompanying professional information.*

FDA Label Image

Polymyxin (Polymyxin Image1)

This appears to be a chemical compound formula. It contains the names of different compounds such as Dab:PheLou, CO-DapThr Dab Dab, Polymyxin B and their respective structural formulas. The formula appears to be incomplete and is not very useful for describing the properties and uses of these compounds.*

FDA Label Image

Polymyxin (Polymyxin Label)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.